NCT01506336View on ClinicalTrials.gov

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2011

Study Completion Date

April 30, 2012

Conditions
Gastro Intestinal Stromal Tumor
Interventions
DRUG

masitinib

masitinib 12 mg/kg/day

DRUG

sunitinib

sunitinib 50 mg/day

Trial Locations (1)

94815

Institute Gustave Roussy (IGR), Villejuif

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY